Back

A combined threshold of 3D global longitudinal strain and extracellular volume identifies the highest-risk phenotype in light-chain cardiac amyloidosis

31 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Myocardial disease and amyloid phenotyping across modalities Imaging of Myocardial Disease ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Fangmin Meng

Shanghai (China)

6 More presentations in this session

Presentation thumbnail
Multimodality imaging assessment of right ventricular longitudinal strain for prognostic stratification in cardiac amyloidosis: a systematic review and meta-analysis
Doctor J. Herrera (Cordoba, ES)
Abstract Slides Video
Presentation thumbnail
Prognostic value of CMR versus FDG-PET in cardiac sarcoidosis: insights from the MYSTICS registry
Doctor A. Sakai (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Accuracy of artificial intelligence-enabled handheld ultrasound devices to assess left ventricular ejection fraction: A systematic review and meta-analysis
Mr J. Winarta (US)
Abstract Slides Video
Presentation thumbnail
Incremental prognostic value of left ventricular global function index, a novel marker of adaptive cardiac remodelling, in hypertrophic cardiomyopathy in a large contemporary cohort
Doctor M. Desai (Cleveland, US)
Abstract Slides Video
Presentation thumbnail
Beyond resting ejection fraction: prognostic value of inotropic reserve in cardio-oncology
Doctor H. Michalopoulou (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Myocardial disease and amyloid phenotyping across modalities

The Event

Event poster

ESC Congress 2026

31 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Echocardiographic risk stratification in light chain and transthyretin amyloidosis: a meta-analysis
31 August 2025
thumbnail
Congress Presentation
Myocardial features, intracardiac thrombosis and coronary artery disease assessment with cardiac computed tomography in cardiac amyloidosis (MYOAMY CT): a proof-of-concept study
17 May 2025
thumbnail
Congress Presentation
Screening performance of a deep learning model versus an automated wall thickness score in biopsy-proven cardiac amyloidosis
28 August 2026
thumbnail
Congress Presentation
CMR extracellular volume identifies low-output hemodynamic phenotype in cardiac amyloidosis and refines risk beyond ejection fraction
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources